Loading...
Challenger Limited
CFIGF•PNK
Financial Services
Insurance - Life
$4.53
$0.00(0.00%)
Challenger Limited (CFIGF) Financial Performance & Income Statement Overview
Review Challenger Limited’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
46.89%
↑ 46.89%
Operating Income Growth
158.50%
↑ 158.50%
Net Income Growth
-54.82%
↓ 54.82%
Operating Cash Flow Growth
-33.75%
↓ 33.75%
Operating Margin
63.28%
↑ 63.28%
Gross Margin
84.88%
↑ 84.88%
Net Profit Margin
4.06%
↑ 4.06%
ROE
3.34%
↑ 3.34%
ROIC
9.10%
↑ 9.10%
Challenger Limited (CFIGF) Income Statement & Financial Overview
Review Challenger Limited's (CFIGF) income statement with detailed quarterly and annual figures.
Metric | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 |
---|---|---|---|---|
Revenue | $1.80B | $1.40B | $1.16B | $1.39B |
Cost of Revenue | $677.00M | -$193.10M | $0.00 | $0.00 |
Gross Profit | $1.12B | $1.60B | $1.16B | $1.39B |
Gross Profit Ratio | $0.62 | $1.14 | $1.00 | $1.00 |
R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
SG&A Expenses | $386.00M | $244.00M | $151.70M | $228.40M |
Operating Expenses | $386.00M | $475.70M | $275.70M | $184.80M |
Total Costs & Expenses | $386.00M | -$997.90M | -$307.20M | -$1.08B |
Interest Income | $0.00 | $576.40M | $401.60M | $288.60M |
Interest Expense | $392.50M | $374.20M | $405.60M | $143.70M |
Depreciation & Amortization | $6.60M | $7.20M | $7.30M | $7.20M |
EBITDA | $488.80M | $449.70M | $857.80M | $325.60M |
EBITDA Ratio | $0.27 | -$0.38 | -$0.42 | -$0.20 |
Operating Income | $1.41B | $612.90M | $705.00M | $331.00M |
Operating Income Ratio | $0.79 | $0.44 | $0.61 | $0.24 |
Other Income/Expenses (Net) | -$1.31B | -$336.00M | -$497.10M | -$143.60M |
Income Before Tax | $104.50M | $68.30M | $207.90M | $174.80M |
Income Before Tax Ratio | $0.06 | $0.05 | $0.18 | $0.13 |
Income Tax Expense | $29.70M | $25.50M | $52.30M | $60.20M |
Net Income | $73.80M | $56.30M | $164.80M | $122.70M |
Net Income Ratio | $0.04 | $0.04 | $0.14 | $0.09 |
EPS | $0.11 | $0.08 | $0.24 | $0.18 |
Diluted EPS | $0.11 | $0.08 | $0.21 | $0.17 |
Weighted Avg Shares Outstanding | $683.30M | $684.30M | $682.79M | $681.08M |
Weighted Avg Shares Outstanding (Diluted) | $702.64M | $698.28M | $960.51M | $853.68M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan